Hap Trading, LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $380,016 - $506,063	10,400 New	10,400 $44,000
Q1 2022 May 12, 2022	SELL	$29.88 - $37.04 $501,984 - $622,272	-16,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $430,248 - $589,680	16,800 New	16,800 $12,000
Q2 2018 Aug 13, 2018	SELL	$40.53 - $50.7 $579,579 - $725,010	-14,300 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$44.08 - $55.05 $70,528 - $88,080	1,600 Added 12.6%	14,300 $4,000
Q4 2017 Feb 09, 2018	BUY	$50.3 - $64.39 $638,810 - $817,753	12,700	12,700 $6,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.